Remove tag life-sciences
article thumbnail

Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)

Rethinking Clinical Trials

Many high school and college students are moving away from the sciences. Work-life balance is a very important issue and will be for the next generation of women and men. Discussion Themes -What have been the challenges in developing and identifying people interested in working in clinical trials? Trainees don’t see a way forward.

article thumbnail

Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)

Rethinking Clinical Trials

Department of Population Health Sciences. Important issues early on included COVID-19’s effects on the workplace, vaccine access and willingness, and impact on home life. ? ? ? ? ? ?. Speakers. Emily O’Brien, PhD, FAHA. Associate Professor. Duke Clinical Research Institute. Duke University School of Medicine. Russell Rothman, MD, MPP.

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approval of First Rapid-Acting Oral Depression Drug + Approval of $2.8 Million Gene Therapy for Rare Blood Disorder – Xtalks Life Science Podcast Ep. 75

XTalks

Hear more about the therapy, some of the setbacks bluebird has had to face on the road to its approval and why the treatment has a steep price tag. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Bluebird’s $2.8M Gene Therapy Zynteglo Wins Landmark FDA Approval for Beta Thalassemia. Bluebird’s $2.8M

article thumbnail

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Rethinking Clinical Trials

Across 5 sessions, GGC4H offers strategies for promoting health and wellbeing, such as setting healthy and clear guidelines, positive discipline, dealing with anger constructively, resisting negative influences (with adolescents) and strengthening bonds and building life skills.

article thumbnail

Grand Rounds October 13, 2023: Incorporating Social Determinants of Health Into PCORnet (Keith Marsolo, PhD)

Rethinking Clinical Trials

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health.

article thumbnail

Scientists and medics turn to TikTok to reassure public on vaccine safety

pharmaphorum

She told the BBC that her approach on TikTok is “come for the entertainment, but stay for the science.” Her videos cover a host of topics from the science behind the immune system, side effects caused by the shots and vaccine hesitancy and the clinical and regulatory path to approval. Dr Austin Chiang.

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

Branding 106